Skip to main content
Access Resources

MJFF Publications

341 - 350 of 7540 Results
Title
Year
  • Year
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • 2023
  • RESTRICTED
    Title: Insight into the Binding of First- and Second-Generation PET Tracers to 4R and 3R/4R Tau Protofibrils
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1021/acschemneuro.3c00437
    Citation Count: 4
  • RESTRICTED
    Title: Frequency and phenotypic spectrum of spinocerebellar ataxia 27B and other genetic ataxias in a Spanish cohort of late‐onset cerebellar ataxia
    Journal Name: European Journal of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1111/ene.16039
    Best OA location URL:
    Citation Count: 6
  • RESTRICTED
    Title: Associations of Apolipoprotein ε4 Genotypes with Motor and Nonmotor Symptoms in Parkinson's Disease: A Cross‐Sectional Study
    Journal Name: Movement Disorders Clinical Practice
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1002/mdc3.13862
    Citation Count: 0
  • RESTRICTED
    Title: The Avidity of Autoreactive Alpha-Synuclein Antibodies in Leucine-Rich Repeat Kinase 2 Mutation Carriers Is Not Altered Compared to Healthy Controls or Patients with Parkinson’s Disease
    Journal Name: Biomolecules
    Publisher: MDPI AG
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.3390/biom13091303
    Citation Count: 0
  • RESTRICTED
    Title: Lifespan neurodegeneration of the human brain in multiple sclerosis
    Journal Name: Human Brain Mapping
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/hbm.26464
    Citation Count: 3
  • RESTRICTED
    Title: Reference LINE-1 insertion polymorphisms correlate with Parkinson’s disease progression and differential transcript expression in the PPMI cohort
    Journal Name: Scientific Reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41598-023-41052-1
    Citation Count: 1
  • RESTRICTED
    Title: Network Connectivity Alterations across the MAPT Mutation Clinical Spectrum
    Journal Name: Annals of Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/ana.26738
    Citation Count: 0
  • RESTRICTED
    Title: Spinal cord and brain concentrations of riluzole after oral and intrathecal administration: A potential new treatment route for amyotrophic lateral sclerosis
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0277718
    Citation Count: 0
  • RESTRICTED
    Title: Transdermal Nicotine Treatment and Progression of Early Parkinson’s Disease
    Journal Name: NEJM Evidence
    Publisher: Massachusetts Medical Society
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1056/evidoa2200311
    Best OA location URL:
    Citation Count: 2
  • RESTRICTED
    Title: Neurofilament light chain in spinal fluid and plasma in multiple system atrophy: a prospective, longitudinal biomarker study
    Journal Name: Clinical Autonomic Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1007/s10286-023-00974-6
    Citation Count: 1
Filters
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.